株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

タンパク質シーケンシングの世界市場:成長、動向、および予測

Protein Sequencing Market - Growth, Trends, and Forecast (2019 - 2024)

発行 Mordor Intelligence LLP 商品コード 911974
出版日 ページ情報 英文 114 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.11円で換算しております。
タンパク質シーケンシングの世界市場:成長、動向、および予測 Protein Sequencing Market - Growth, Trends, and Forecast (2019 - 2024)
出版日: 2019年09月01日 ページ情報: 英文 114 Pages
担当者のコメント
下記の日本語概要は、最新版レポートの内容と異なる場合があります。詳細はお問合せください。
概要

当レポートは世界のタンパク質シーケンシング市場について調査しており、市場機会や動向、成長および阻害要因、製品/サービス・用途・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

  • 調査成果
  • 調査の前提条件
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概況
  • 成長要因
  • 阻害要因
  • ポーターのファイブフォース分析

第5章 市場セグメント

  • 製品・サービス別
    • 機器
    • 試薬・消耗品
    • ソフトウェアとサービス
  • 用途別
  • エンドユーザー別
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Agilent Technologies, Inc.
    • Bioinformatics Solutions
    • Charles River Laboratories
    • Proteome Factory
    • Rapid Novor Inc.
    • Selvita SA
    • SGS SA
    • 株式会社島津製作所
    • Thermo Fisher Scientific Inc.
    • Waters

第7章 市場機会および今後の動向

目次
Product Code: 66829

Market Overview

The major factors for the growth of the protein sequencing market include the rising focus on target-based drug development, and increasing funding for proteomics research.

The rising funding for proteomic research is expected to boost the protein sequencing market over the forecast period. In the United States, the Office of Cancer Clinical Proteomics Research (OCCPR) supports the development of technologies and reagents that will advance understanding of protein biology in cancer. Furthermore, recently on January 2018, more than USD 18 million in funding awarded to two national platforms in which the University of Victoria plays a key role to improve the diagnosis and treatment of various diseases such as cancer and Alzheimer's. In addition, one of the market player Biognosys, on July 2017 announced that it has secured USD 5 million funding from new and existing investors in an extended series C round. Thus, rising funding for proteomic research is expected to propel the overall growth of the market over the forecast period.

Scope of the Report

As per the scope of this report, protein sequencing is the process of determining the amino acid sequence of all or part of a protein or peptide. This techniques are helpful in the identification of proteins and characterize their post-translational modifications. The market is segmented by products and services, application, end-user, and geography.

Key Market Trends

Protein Engineering Studies is the Segment by Application expected to be the Fastest-Growing Segment

Protein engineering is the manipulation of the structures of proteins to produce the desired properties or the synthesis of proteins with particular structures. The majority of therapeutic drugs in the current market are bio formulations, such as antibodies, nucleic acid products, and vaccines. The companies are focusing on field in protein engineering for the site-specific conjugation of functional moieties to biopharmaceuticals is the incorporation of unnatural amino acids (uAA). The rapid developments in post-translational engineering and strain development to produce better-defined products, faster approval of biopharmaceuticals can be expected. Furthermore, according to the data published by the Genetics & Protein Engineering Conferences 2018, roughly 3,000 professionals from 60 over universities in the country, currently working on protein engineering. Thus, owing to the rising focus on protein engineering the market is expected to witness high growth.

North America is Expected to Hold Largest Market Share over the Forecast Period

The United States is expected to be the largest protein sequencing market owing to the rising technological advancements and the presence of better healthcare infrastructure. In the United States, the pharmaceutical industry is one of the most research-intensive organizations. And this pharmaceutical industry is deeply invested in applying innovative solutions to enhance the pipeline development to support improvements in patient care. Furthermore, there is a rising focus on target-based drug development and protein sequencing studies helping in target-based drug development. Also, government and non-government organizations are providing funds to carry out research in the field of proteomics. Thus, owing to all above-mentioned factors the market is expected to witness high growth over the forecast period.

Competitive Landscape

The market studied is a fragmented market owing to the presence of various market players. Some of the market players are Agilent Technologies, Inc., Bioinformatics Solutions, Charles River Laboratories, Proteome Factory, Rapid Novor Inc., Selvita SA, SGS SA, Shimadzu Corporation, Thermo Fisher Scientific Inc., and Waters

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Focus on Target based Drug Development
    • 4.2.2 Increasing Funding for Proteomic Research
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Infrastructures and Equipment
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Products and Services
    • 5.1.1 Instruments
      • 5.1.1.1 Mass Spectrometry
      • 5.1.1.2 Edman Degradation
    • 5.1.2 Reagents and Consumables
    • 5.1.3 Softwares and Services
  • 5.2 By Application
    • 5.2.1 Biomarker Discovery
    • 5.2.2 Protein Engineering Studies
    • 5.2.3 Biotherapeutics
    • 5.2.4 Others
  • 5.3 By End User
    • 5.3.1 Pharmaceutical & Biotechnology Companies
    • 5.3.2 Research Centers
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 UK
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Agilent Technologies, Inc.
    • 6.1.2 Bioinformatics Solutions
    • 6.1.3 Charles River Laboratories
    • 6.1.4 Proteome Factory
    • 6.1.5 Rapid Novor Inc.
    • 6.1.6 Selvita SA
    • 6.1.7 SGS SA
    • 6.1.8 Shimadzu Corporation
    • 6.1.9 Thermo Fisher Scientific Inc.
    • 6.1.10 Waters

7 MARKET OPPORTUNITIES AND FUTURE TRENDS